saplin

Compare funds

Nippon India Value vs DSP Value

Both are value fund funds. Over the last 3 years Nippon India Value returned 13.4% a year and DSP Value 17.7%, against a category median of 13.4%. Nippon India Value costs 1.24% a year and DSP Value 1.44%. On the saplin Score Nippon India Value rates 6.8 (Neutral) and DSP Value 8.3 (Strong) within their category. 32.4% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

Nippon India ValueDSP ValueCategory median
saplin Score (0–10)6.8 Neutral8.3 Strong—
1-year return-3.9%7.8%1.0%
3-year return, a year13.4%17.7%13.4%
5-year return, a year12.6%13.6%13.0%
Volatility (standard deviation)16.8%11.8%15.8%
Sharpe ratio0.470.940.49
Beta1.030.670.96
Upside capture10687100
Downside capture1054595
Expense ratio (Direct)1.24%1.44%1.17%
Fund size₹8,976 cr₹2,167 cr₹1,804 cr
Number of holdings884562
Top 10 holdings, share of fund37.1%39.8%37.9%
Portfolio P/E22.518.720.7
Lead managerDhrumil Shah (4 yrs)Abhishek Singh (1 yr)—
Launched8 Jun 200510 Dec 2020—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

Nippon India Value and DSP Value have 32.4% of their portfolios in the same stocks (17 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsNippon India ValueDSP Value
HDFC Bank7.16%8.88%
ICICI Bank3.49%8.35%
NTPC3.63%3.21%
Axis Bank3.90%2.37%
Bharti Airtel2.69%2.28%
State Bank of India3.93%1.95%
ITC1.95%2.49%
Infosys1.91%2.96%
Kotak Mahindra Bank4.63%1.79%
Larsen & Toubro2.16%1.32%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.